BioCentury
ARTICLE | Clinical News

Davunetide: Additional Phase IIa data

April 5, 2010 7:00 AM UTC

Data from a subset of 18 chronic schizophrenics from a double-blind, U.S. Phase IIa trial showed that intranasal davunetide significantly increased levels of N-acetyl aspartate as measured by magnetic...